Nimotuzumab Enhances the Radiosensitivity of Cancer Cells In Vitro by Inhibiting Radiation-Induced DNA Damage Repair
作者： Yuan-yuan Qu , Song-liu Hu , Xiang-ying Xu , Rui-zhi Wang , Hong-yang Yu
DOI: 10.1371/JOURNAL.PONE.0070727
关键词:
摘要: Background Nimotuzumab is a humanized IgG1 monoclonal antibody specifically targeting EGFR. In this study, we aimed to investigate the molecular mechanisms of nimotuzumab in its effects enhancing cancer cell radiosensitivity.
paperity.org
harvard.edu
core.ac.uk 参考文章(25)
Alexandra D. Jensen, Marc W. Münter, Helge G. Bischoff, Renate Haselmann, Uwe Haberkorn, Peter E. Huber, Michael Thomas, Jürgen Debus, Klaus K. Herfarth, Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity‐modulated RT radiotherapy and cetuximab Cancer. ,vol. 117, pp. 2986- 2994 ,(2011) , 10.1002/CNCR.25888
Klaus Dittmann, Claus Mayer, Hans-Peter Rodemann, Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity Radiotherapy and Oncology. ,vol. 76, pp. 157- 161 ,(2005) , 10.1016/J.RADONC.2005.06.022
Klaus Dittmann, Claus Mayer, Birgit Fehrenbacher, Martin Schaller, Uma Raju, Luka Milas, David J. Chen, Rainer Kehlbach, H. Peter Rodemann, Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase Journal of Biological Chemistry. ,vol. 280, pp. 31182- 31189 ,(2005) , 10.1074/JBC.M506591200
Chetana Basavaraj, Patricia Sierra, Jatteppanavar Shivu, Ramakrishnan Melarkode, Enrique Monte, Pradip Nair, Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR. Cancer Biology & Therapy. ,vol. 10, pp. 673- 681 ,(2010) , 10.4161/CBT.10.7.12793
Jun Wang, Lu-Jun Zhao, Ping Wang, Xiu-Bao Ren, Chang-Li Wang, Hong-Qing Zhuang, Jian Sun, Zhi-Yong Yuan, Radiosensitizing effects of gefitinib at different administration times in vitro Cancer Science. ,vol. 100, pp. 1520- 1525 ,(2009) , 10.1111/J.1349-7006.2009.01190.X
Y Akashi, I Okamoto, T Iwasa, T Yoshida, M Suzuki, E Hatashita, Y Yamada, T Satoh, M Fukuoka, K Ono, K Nakagawa, Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status British Journal of Cancer. ,vol. 98, pp. 749- 755 ,(2008) , 10.1038/SJ.BJC.6604222
Greta Garrido, Ilia A Tikhomirov, Ailem Rabasa, Eric Yang, Elías Gracia, Normando Iznaga, Luis E Fernández, Tania Crombet, Robert S Kerbel, Rolando Pérez, None, Bivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profile. Cancer Biology & Therapy. ,vol. 11, pp. 373- 382 ,(2011) , 10.4161/CBT.11.4.14097
Melarkode S. Ramakrishnan, Anand Eswaraiah, Tania Crombet, Patricia Piedra, Giselle Saurez, Harish Iyer, A.S. Arvind, Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin. mAbs. ,vol. 1, pp. 41- 48 ,(2009) , 10.4161/MABS.1.1.7509
Apar Ganti, Reade, EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab. Biologics: Targets & Therapy. ,vol. 3, pp. 215- 224 ,(2009) , 10.2147/BTT.S4479
Marta Osorio Rodríguez, Teresa Cruz Rivero, Ramón del Castillo Bahi, Carlos Roca Muchuli, Miguel Azcue Bilbao, Elia Neninger Vinageras, José Alert, Julio Jiménez Galainena, Edmundo Rodríguez, Elías Gracia, Bárbara Mulén, Bárbara Wilkinson, Esther Lucía de Armas, Kirenia Pérez, Idael Pineda, Milagros Frómeta, Idrissa Leonard, Vladimir Mullens, Carmen Viada, Patricia Luaces, Olga Torres, Normando Iznaga, Tania Crombet, None, Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck. Cancer Biology & Therapy. ,vol. 9, pp. 343- 349 ,(2010) , 10.4161/CBT.9.5.10981